Agricultural / Industrial Biotechnology Archives - MassBio https://www.massbio.org/member-category/a6ff131d-834c-e311-ba25-b4b52f662bc2/ Massachusetts Biotechnology Council Tue, 02 Jan 2024 22:33:05 +0000 en-US hourly 1 https://wordpress.org/?v=6.3.2 Eledon Pharmaceuticals https://www.massbio.org/members/anelixis-therapeutics-inc/ Wed, 29 Nov 2023 13:31:10 +0000 https://www.massbio.org/members/anelixis-therapeutics-inc/ The post Eledon Pharmaceuticals appeared first on MassBio.

]]> The post Eledon Pharmaceuticals appeared first on MassBio.

]]> Arcaea https://www.massbio.org/members/arcaea/ Tue, 28 Nov 2023 13:32:25 +0000 https://www.massbio.org/members/arcaea/ The post Arcaea appeared first on MassBio.

]]> The post Arcaea appeared first on MassBio.

]]> ArkeaBio Corp. https://www.massbio.org/members/arkea-bio-corp/ Tue, 28 Nov 2023 13:32:25 +0000 https://www.massbio.org/members/arkea-bio-corp/ ArkeaBio is using innovative vaccine technologies to create solutions to reduce the on-farm methane emissions responsible for 6% of global GHG emissions. ArkeaBio technology will be integrated into proven delivery systems and farming practices to safely reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems. 

The post ArkeaBio Corp. appeared first on MassBio.

]]>

ArkeaBio is using innovative vaccine technologies to create solutions to reduce the on-farm methane emissions responsible for 6% of global GHG emissions. ArkeaBio technology will be integrated into proven delivery systems and farming practices to safely reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems. 

The post ArkeaBio Corp. appeared first on MassBio.

]]> Avilar Therapeutics https://www.massbio.org/members/avilar-therapeutics/ Tue, 28 Nov 2023 13:32:27 +0000 https://www.massbio.org/members/avilar-therapeutics/ The post Avilar Therapeutics appeared first on MassBio.

]]> The post Avilar Therapeutics appeared first on MassBio.

]]> BeBiopharma https://www.massbio.org/members/bebiopharma/ Tue, 02 Jan 2024 17:33:05 +0000 https://www.massbio.org/members/bebiopharma/ Be Biopharma (“Be Bio”) is pioneering Engineered B Cell Medicines (BeCM) to dramatically improve patients’ lives who are living with cancer, rare diseases and other serious conditions. With eyes locked on the patient, our team of purpose-driven scientists, technologists, manufacturing experts and business builders collaborate to create a bold new class of cell therapies. Be […]

The post BeBiopharma appeared first on MassBio.

]]> Be Biopharma (“Be Bio”) is pioneering Engineered B Cell Medicines (BeCM) to dramatically improve patients’ lives who are living with cancer, rare diseases and other serious conditions. With eyes locked on the patient, our team of purpose-driven scientists, technologists, manufacturing experts and business builders collaborate to create a bold new class of cell therapies. Be Bio was founded in October 2020 by Longwood Fund and B cell engineering pioneers David Rawlings, M.D., and Richard James, Ph.D. from Seattle Children’s Research Institute. Be Bio is backed by ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers Squibb and Takeda Ventures. Since our founding, Be Bio’s investors have committed over $180 million to enable the Company to re-imagine medicine based on the power of B cell therapy. For more information, please visit us at Be.Bio and our LinkedIn page.

The post BeBiopharma appeared first on MassBio.

]]> Boan Boston LLC https://www.massbio.org/members/boan-boston-llc/ Tue, 28 Nov 2023 13:32:30 +0000 https://www.massbio.org/members/boan-boston-llc/ Boan Biotech is a fully integrated biopharmaceutical company, specializing in the research & development, manufacturing, and commercialization of novel therapeutic antibodies, cell and gene therapies, which are mainly focused on key therapeutic areas such as oncology, diabetes, and immunological diseases.

The post Boan Boston LLC appeared first on MassBio.

]]> Boan Biotech is a fully integrated biopharmaceutical company, specializing in the research & development, manufacturing, and commercialization of novel therapeutic antibodies, cell and gene therapies, which are mainly focused on key therapeutic areas such as oncology, diabetes, and immunological diseases.

The post Boan Boston LLC appeared first on MassBio.

]]> Catalog Technologies, Inc. https://www.massbio.org/members/catalog-technologies-inc/ Tue, 14 Nov 2023 15:31:11 +0000 https://www.massbio.org/members/catalog-technologies-inc/ Catalog is harnessing the power of DNA to enable the next generation of digital data archives.

The post Catalog Technologies, Inc. appeared first on MassBio.

]]> Catalog is harnessing the power of DNA to enable the next generation of digital data archives.

The post Catalog Technologies, Inc. appeared first on MassBio.

]]> CJ Biomaterials, Inc https://www.massbio.org/members/cj-research-center/ Tue, 02 Jan 2024 16:02:09 +0000 https://www.massbio.org/members/cj-research-center/ CJ Research Center is an exciting new company founded as the hub of CJ's innovative biotechnology. As a subsidiary of the South Korean conglomerate, CJ CheilJedang, the CJ Research Center will benefit from many of the bio businesses CJ CheilJedang has established around the world, including: food, food ingredient, pharmaceuticals, animal feed, and amino acid/nucleotide […]

The post CJ Biomaterials, Inc appeared first on MassBio.

]]> CJ Research Center is an exciting new company founded as the hub of CJ's innovative biotechnology. As a subsidiary of the South Korean conglomerate, CJ CheilJedang, the CJ Research Center will benefit from many of the bio businesses CJ CheilJedang has established around the world, including: food, food ingredient, pharmaceuticals, animal feed, and amino acid/nucleotide feed supplements. CJ recognized the potential commercial synergy between these bio businesses and the proprietary PHA biopolymer technology pioneered by Metabolix/Yield 10 Biosciences. Creating a firm foundation for the new Research Center, CJ acquired the core technology of Metabolix as well as the molecular biology and fermentation labs located in Woburn, MA. Taking advantage of the vast academic and industry resources clustered in the Boston/Cambridge area, CJ has assembled a world class technical team to continue development of the biopolymer technology through advanced bacterial strain engineering methods and fermentation process precision and throughput improvements. The CJ Research Center will explore new technologies and pursue unique, cutting-edge approaches to expand into other life sciences.

The post CJ Biomaterials, Inc appeared first on MassBio.

]]> Cognesy Therapeutics https://www.massbio.org/members/cognesy-therapeutics/ Tue, 14 Nov 2023 15:31:14 +0000 https://www.massbio.org/members/cognesy-therapeutics/ The post Cognesy Therapeutics appeared first on MassBio.

]]> The post Cognesy Therapeutics appeared first on MassBio.

]]> Edge Animal Health https://www.massbio.org/members/edge-animal-health/ Tue, 02 Jan 2024 16:02:10 +0000 https://www.massbio.org/members/edge-animal-health/ The post Edge Animal Health appeared first on MassBio.

]]> The post Edge Animal Health appeared first on MassBio.

]]>